Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-17

Clinical Trial Update: Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis [NA]

View source ↗

Summary

A completed randomized trial comparing crisaborole to fluticasone propionate for mild-to-moderate atopic dermatitis (eczema).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eucrisa (crisaborole)
  • Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: Noura Abdelmoneim Mohammed Elseessy | Conditions: Atopic Dermatitis, Eczema | NA | Status: COMPLETED